TL;DR Rybelsus (oral semaglutide) outperforms Januvia (sitagliptin) in nearly every clinical measure for adults with type 2 diabetes
This can also be associated with hearing loss
Some muscle loss can occur during rapid weight reduction, especially with low protein intake
PlexusDx oral semaglutide is $289/mo month-to-month (or $249/mo on the 6-month plan), while oral tirzepatide is $349/mo month-to-month, or from $279/mo on the 6-month plan
Processed or very fatty protein sources may increase nausea or discomfort given the medication's effect on stomach motility
The clinical trials market is expanding due to factors such as the rising prevalence of chronic diseases, rising number of clinical trials in developing regions, increasing incidence of biologics, rapidly increasing demand for advanced treatments such as personalized medicines, viral disease outbreaks, rising cancer cases globally, rising geriatric population, and rising R&D expenditure